Rationale and Design of the Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering (MIRACL) Study 1 1 See Appendix Afor the list of participants in the MIRACL study. That Evaluates Atorvastatin in Unstable Angina Pectoris and in Non–Q-Wave Acute Myocardial Infarction
Titel:
Rationale and Design of the Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering (MIRACL) Study 1 1 See Appendix Afor the list of participants in the MIRACL study. That Evaluates Atorvastatin in Unstable Angina Pectoris and in Non–Q-Wave Acute Myocardial Infarction
Auteur:
Schwartz MD, PhD, Gregory G Oliver MD, FRCP, Michael F Ezekowitz MD, PhD, Michael D Ganz MD, Peter Waters MD, David Kane MD, PhD, John P Texter MS, Michele Pressler MD, Milton L Black MD, Donald Chaitman MD, Bernard R Olsson MD, PhD, Anders G